FDA.reportPublic FDA data

Covaryx HS 0.625 MG / 1.25 MG Oral Tablet

RxCUI
705921
RxNorm name
Covaryx HS 0.625 MG / 1.25 MG Oral Tablet
Display name
Covaryx HS 0.625 MG / 1.25 MG Oral Tablet
Full name
Covaryx HS 0.625 MG / 1.25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e4ff7b6b-ce78-402c-9c0e-b8b0d9636eaeCovaryx HS 0.625 MG / 1.25 MG Oral Tablet [PSN] · estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Covaryx] [SBD] · Covaryx (estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG) Oral Tablet [SY] · Covaryx HS (estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG) Oral Tablet [SY]42COVARYX20200125